In less than 24 hours after the arrival of four million doses of AstraZeneca COVID-19 vaccines, about 2.3 million Nigerians across the country have registered for vaccination.
The Executive Director, National Primary Health Care Development Agency (NPHCDA), Dr. Faisal Shuaib, announced the figure yesterday.
He stated this while dispelling fears that people might not want to be vaccinated against COVID-19 due to many impressions surrounding the vaccines’ origin.
According to him: “I can tell you that there is a lot of excitement about the vaccines’ arrival. I know some people have their concerns and we are trying, but I want to give you an example of the enthusiasm that Nigerians are showing around wanting to take these vaccines.
“Around midday on Monday when we launched the e-registration platform, in less than 24 hours, we already had up to 2.3m Nigerians who had registered. And that number continues to increase,” Shuaib said during an interview on a live television programme.
DAILY POST had reported that the country, on Tuesday received 3.94 million doses of the AstraZeneca/Oxford vaccine, manufactured by the Serum Institute of India(SII) and shipped via the COVAX facility.
Recall also that the Presidential Task Force (PTF) on COVID-19 has said that Nigerians under the age of 18 years will not participate in the planned mass vaccination.
The Task Force had also warned that private organisations were not permitted to procure, distribute and administer the coronavirus vaccines.
You may be interested
Man Sentenced To 12 Years In Prison For Killing Kogi PDP Women Leader, Salome AbuhWebby - March 23, 2021
A High Court sitting in Idah, Kogi State, has convicted and sentenced one Ocholi Edicha for the killing of Mrs.…
Gbajabiamila overrules deputy, accepts petition from diasporan TivsWebby - March 23, 2021
House of Representatives speaker, Femi Gbajabiamila, has overruled Ahmed Idris Wase, his deputy, who rejected a petition by “Mutual Union…
You’re a coward feeding on commonwealth of Ondo people— Group slams Akeredolu over oppositionWebby - March 23, 2021
[unable to retrieve full-text content]